UCLH is the highest recruiter among UCLPartners (UCLP) organisations in 2021 to clinical trials run in conjunction with the healthcare company IQVIA.
Patient and public involvement (PPI) training brings about immediate and marked increases in the confidence and skills of researchers to involve the public in their work, according to a study at the BRC.
A national study involving UCLH has deepened understanding of the symptoms, signs and outcomes of patients with the novel condition vaccine-induced immune thrombocytopenia and thrombosis (VITT), associated with the Oxford/AstraZeneca vaccine.
UCLH and Cambridge University in collaboration with NHS Blood and Transplant have won government funding to apply artificial intelligence (AI) to improve blood transfusions.
UCLH is carrying out a three-month assessment of its delivery of race equality in health research as part of a project led by the National Institute of Health Research (NIHR).
Study sheds light on treatment of rare cases of blood clotting in the brain following Covid-19 vaccination
A new UCLH and UCL-led observational study of patients with cerebral venous thrombosis (CVT) following COVID-19 vaccination provides a clearer guide to clinicians trying to diagnose and treat patients.
Antibodies produced by SARS-CoV-2 variants vary in ability to neutralise other variants of the virus
Antibodies produced by SARS-CoV-2 variants differ in their ability to neutralise other variants of the virus, according to research by UCLH and the Francis Crick Institute.
The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers and based on the ketogenic diet, has been successfully completed.
Blood cancer patients are at increased risk of severe disease from Covid-19 and less likely to be protected by vaccination
How would you feel if artificial intelligence (AI) played a role in your healthcare decisions? Should AI be used in healthcare? And who is to blame if it goes wrong? How does it work? That’s exactly what we want to find out, as we have collaborated with a group of artists to design a brand-new audience-centric scenario experience that is open for all to participate in.
A major new consortium led by University College London Hospitals NHS Foundation Trust (UCLH) and UCL has been awarded £6.8 million by the National Institute of Health Research (NIHR) to conduct the largest clinical study of long COVID over the next two years. As countries around the world struggle
A clinical trial of a new drug candidate for Alzheimer’s disease which has been developed at UCL in partnership with the pharmaceutical company Eisai has begun at UCLH with participants now being screened.
The first patient in the world has been dosed at the NIHR UCLH Clinical Research Facility (CRF) in a first-in-human trial of a new drug for the rare disease classical homocystinuria.
A UCLH-led trial for patients with brain cancer has recruited more UK participants than ever before for a study of its kind.
UCLH, UCL and spinout company Odin Vision have used artificial intelligence (AI) to help detect early signs of oesophageal cancer in a global first.